Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001649024-17-000002
Filing Date
2017-09-05
Accepted
2017-09-05 13:29:02
Documents
1
Effectiveness Date
2017-09-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7945
  Complete submission text file 0001649024-17-000002.txt   9063
Mailing Address 2207 CRESTMOOR ROAD NASHVILLE TN 37215
Business Address 2207 CRESTMOOR ROAD NASHVILLE TN 37215 615-383-6166
Amytrx Therapeutics, Inc. (Filer) CIK: 0001649024 (see all company filings)

EIN.: 465371128 | State of Incorp.: TN | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-294041 | Film No.: 171068149